Company
Every investor coverage indicates participated in a round CytoTherapeutics raised.
Companies CytoTherapeutics acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Tom Wiggans | President and Chief Operating Officer (former) | GBS Ventures |
Stories naming CytoTherapeutics. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Peplin hires Tom Wiggans as CEO and Eugene Bauer as President/CMO while Michael Aldridge steps down; the dermatology company also announces a US$24m capital raising and a merger agreement with Neosil.
Also GBS Ventures